![Lawrence Blatt](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Lawrence Blatt
Chief Executive Officer at
ALIGOS THERAPEUTICS, INC.
Net worth: 503 971 $ as of 2026-05-30
Profile
Lawrence M.
Blatt was the founder of Alios BioPharma, Inc., founded in 2008, serving as President, Chief Executive Officer & Director from 2009 to 2014.
Dr. Blatt was the founder of Alveo Technologies, Inc., founded in 2014, serving as Chairman.
Dr. Blatt is the founder of Aligos Therapeutics, Inc., founded in 2018, serving as Chairman, President & Chief Executive Officer since 2024.
The current job is Director at Global Virus Network.
Former jobs include Chairman at Meissa Vaccines, Inc., Non-Executive Director at ReViral Ltd., Global Head-Infectious Diseases & Vaccines at Johnson & Johnson from 2014 to 2018, Vice President-Research at Sirna Therapeutics, Inc. from 1998 to 2002, Chief Scientific Officer at InterMune, Inc. from 2002 to 2008, and Vice President-Product Development at National Genetics Institute, Inc. from 1996 to 1998.
Education includes an MBA from California State University-Northridge, an undergraduate degree from Indiana University, and a doctorate from the University of La Verne.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-03-30 | 88,416 ( 1.64% ) | 503 971 $ | 2026-05-30 |
Lawrence Blatt active positions
| Companies | Position | Start |
|---|---|---|
| ALIGOS THERAPEUTICS, INC. | Chief Executive Officer | 2018-02-04 |
Global Virus Network
 Global Virus Network Miscellaneous Commercial ServicesCommercial Services Researches on essential and critical defense against viral disease | Director/Board Member | - |
Former positions of Lawrence Blatt
| Companies | Position | End |
|---|---|---|
| JOHNSON & JOHNSON | Corporate Officer/Principal | 2018-01-31 |
Alios BioPharma, Inc.
 Alios BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company which develops novel antiviral therapies for the treatment of respiratory diseases | Founder | 2014-10-31 |
| INTERMUNE INC | Chief Tech/Sci/R&D Officer | 2007-12-31 |
Sirna Therapeutics, Inc.
 Sirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Provides and develops pharmaceutical products | Chief Tech/Sci/R&D Officer | 2002-04-30 |
National Genetics Institute, Inc.
 National Genetics Institute, Inc. Chemicals: SpecialtyProcess Industries Provides hepatitis C testing and other laboratory services | Corporate Officer/Principal | 1997-12-31 |
Training of Lawrence Blatt
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
67
1st degree connections
13
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 13 |
|---|---|
Johnson & Johnson
 Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
Sirna Therapeutics, Inc.
Sirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Provides and develops pharmaceutical products | Commercial Services |
InterMune, Inc.
 InterMune, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that researches and develops therapies in pulmonology & orphan fibrotic diseases | Health Technology |
Alios BioPharma, Inc.
Alios BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company which develops novel antiviral therapies for the treatment of respiratory diseases | Health Technology |
National Genetics Institute, Inc.
National Genetics Institute, Inc. Chemicals: SpecialtyProcess Industries Provides hepatitis C testing and other laboratory services | Process Industries |
California State University-Northridge
 California State University-Northridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Indiana University
 Indiana University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of La Verne
 University of La Verne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Global Virus Network
Global Virus Network Miscellaneous Commercial ServicesCommercial Services Researches on essential and critical defense against viral disease | Commercial Services |
ReViral Ltd.
 ReViral Ltd. BiotechnologyHealth Technology Develops novel antiviral therapeutics | Health Technology |
Alveo Technologies, Inc.
 Alveo Technologies, Inc. Medical SpecialtiesHealth Technology Operates a pre-clinical stage medical diagnostics company that creates infectious disease diagnostic devices | Health Technology |
Meissa Vaccines, Inc.
 Meissa Vaccines, Inc. BiotechnologyHealth Technology Develops vaccines for respiratory syncytial virus and rhinovirus | Health Technology |
Aligos Therapeutics, Inc.
 Aligos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops targeted, curative therapies for hepatologic diseases and viral infections | Health Technology |
- Stock Market
- Insiders
- Lawrence Blatt
